Cromoglicate in Mastocytosis

Status Terminated

Clinical Trial Summary

The purpose of this exploratory study is to investigate the clinical efficacy of study drug (LP0074) in the treatment of Mastocytosis. The trial will be performed as a left/right comparison study in male/female subjects with mastocytosis, in a prospective, double-blinded, randomised, single centre setting.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Mastocytosis

Clinical Trial Details

NCT number	NCT01701843
Study type	Interventional
Source	LEO Pharma
Contact
Status	Terminated
Phase	Phase 2
Start date	October 2012
Completion date	February 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01333293` - The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients	Phase 2/Phase 3
Completed	`NCT01481909` - Study on Mastocytosis for Rupatadine Treatment	Phase 2/Phase 3
Recruiting	`NCT00044122` - Study of Factors Regulating Mast Cell Proliferation
Recruiting	`NCT06440148` - Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis
Recruiting	`NCT03340155` - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases	N/A
Not yet recruiting	`NCT05084872` - Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients	Phase 2/Phase 3
Completed	`NCT00831974` - Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis	Phase 2
Completed	`NCT00047918` - Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing	N/A
Completed	`NCT00006413` - Stem Cell Transplantation to Treat Systemic Mastocytosis	Phase 2
Completed	`NCT00050193` - Cause and Natural Course of Pediatric-Onset Mastocytosis
Completed	`NCT02620254` - Mast Cell Connect: A Registry for Patients With Mastocytosis
Completed	`NCT00255346` - Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)	Phase 2
Completed	`NCT00001356` - Characteristics of Mast Cells in Mastocytosis	N/A
Recruiting	`NCT06466889` - Mastocytosis Registry (of Zurich)
Recruiting	`NCT05186753` - (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis	Phase 2
Completed	`NCT02478957` - Treatment of Indolent Systemic Mastocytosis With PA101	Phase 2
Recruiting	`NCT02450396` - Pregnancy and Medically Assisted Conception in Rare Diseases
Completed	`NCT00038675` - Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate	N/A
Not yet recruiting	`NCT06432556` - Study of Cellular Heterogeneity in Patients With Mastocytosis	N/A
Completed	`NCT00336076` - Molecular Mechanisms and Diagnosis of Mastocytosis	N/A